Print
Email
Print Edition StoriesThursday, July 24, 2008
Mass. Life Sciences Center adds board members, awards $6M in grants
By Mass High Tech Staff
The Massachusetts Life Sciences Center, the state agency focused on directing investment in the life sciences sector of the commonwealth, reports it has new members on its board of directors and has awarded $6.6 million in grants.
The board appointments and grant awards are the first major actions by the agency since Gov. Deval Patrick signed a $1 billion stimulus bill for life sciences into law June 16.
The agency’s new board members include: Joshua Boger, CEO of Vertex Pharmaceuticals Inc. (Nasdaq: VRTX), of Cambridge; Leslie Kirwan, secretary of administration and finance in the Patrick administration, who is cochairing the Life Sciences Center board; Lydia Villa-Komaroff, CEO of Boston life sciences startup Cytonome Inc.; and Peter Slavin, president of Massachusetts General Hospital in Boston.
The newly formed board approved $3.5 million in grants to be awarded to five Massachusetts universities to retain prominent, life sciences faculty as well as 11 research grants for Bay State institutions totaling $3.1 million.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
